MYUNGMOON PharmLtd Balance Sheet Health
Financial Health criteria checks 4/6
MYUNGMOON PharmLtd has a total shareholder equity of ₩88.8B and total debt of ₩89.1B, which brings its debt-to-equity ratio to 100.4%. Its total assets and total liabilities are ₩236.5B and ₩147.8B respectively. MYUNGMOON PharmLtd's EBIT is ₩963.8M making its interest coverage ratio 0.2. It has cash and short-term investments of ₩11.7B.
Key information
100.4%
Debt to equity ratio
₩89.10b
Debt
Interest coverage ratio | 0.2x |
Cash | ₩11.66b |
Equity | ₩88.75b |
Total liabilities | ₩147.79b |
Total assets | ₩236.55b |
Recent financial health updates
MYUNGMOON PharmLtd (KRX:017180) Has No Shortage Of Debt
Mar 21Does MYUNGMOON PharmLtd (KRX:017180) Have A Healthy Balance Sheet?
Mar 31Does Myungmoon Pharm (KRX:017180) Have A Healthy Balance Sheet?
Dec 15Recent updates
MYUNGMOON PharmLtd (KRX:017180) Has No Shortage Of Debt
Mar 21Does MYUNGMOON PharmLtd (KRX:017180) Have A Healthy Balance Sheet?
Mar 31Introducing MYUNGMOON PharmLtd (KRX:017180), A Stock That Climbed 77% In The Last Five Years
Feb 06Does Myungmoon Pharm (KRX:017180) Have A Healthy Balance Sheet?
Dec 15Financial Position Analysis
Short Term Liabilities: A017180's short term assets (₩81.4B) do not cover its short term liabilities (₩116.4B).
Long Term Liabilities: A017180's short term assets (₩81.4B) exceed its long term liabilities (₩31.4B).
Debt to Equity History and Analysis
Debt Level: A017180's net debt to equity ratio (87.2%) is considered high.
Reducing Debt: A017180's debt to equity ratio has reduced from 108.3% to 100.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A017180 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A017180 has sufficient cash runway for 1 years if free cash flow continues to grow at historical rates of 17.4% each year.